Avantor, Inc. (AVTR)
NYSE
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
16.9052 wk Range
7.26Overview - AVTR - Avantor, Inc.
Key Statistics
Valuation
Enterprise Value
13.98B
P/E (Trailing)
14.85
P/E (Forward)
17.86
PEG Ratio
-0.44
Price / Sales (TTM)
1.61
Price / Book
1.88
EV / EBITDA
14.82
Profitability
Gross Margin
31.73%
Profit Margin
-8.80%
Operating Margin
7.16%
Return on Assets
2.69%
Return on Equity
-9.70%
Ownership
Shares Outstanding
676.50M
Float
657.80M
Short % of Shares Outstanding
7.06%
Held by Insiders
1.52%
Held by Institutions
105.37%
Price stats
Beta
0.93
50-Day Avg
14.64
200-Day Avg
10.84
Dividends
Payout Ratio
0.00%
Analyst Consensus
15 analysts
Average price target
$ 14.56Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AVTR - Avantor, Inc.
Peers - AVTR - Avantor, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - AVTR - Avantor, Inc.
About
Avantor, Inc. is a global life science tools and advanced technology company that supplies mission-critical products and services to customers in biopharma, healthcare, education and government, and applied materials industries. Its portfolio includes laboratory chemicals, reagents, consumables, equipment,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
